Literature DB >> 15780747

Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development.

Gregory J Pelka1, Catherine M Watson, John Christodoulou, Patrick P L Tam.   

Abstract

Four different transcripts of the Mecp2 gene can be distinguished by the length of the 3' untranslated region generated by usage of alternative polyadenylation sites. In situ hybridization analyses encompassing embryonic to 20-week postnatal age showed that transcripts are expressed in the central nervous system, with a progressive restriction during development culminating in localized strong expression in the cerebral cortex, olfactory bulb, hippocampal formation, and internal granule and Purkinje layer of the cerebellum. Real-time RT-PCR measurements of Mecp2 transcript levels showed variations with mouse age in two distinctive patterns that are unique to the central nervous system and the visceral organs, respectively. The 10-kb mRNA is the predominant form expressed in the brain in contrast to the shorter species expressed in the lung and liver. The developmental profile of Mecp2 mRNA highlights a potential tissue-specific function of the 3'UTR in the regulation of MeCP2 protein synthesis in response to the age-specific requirement of MeCP2 function during the life of the mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780747     DOI: 10.1016/j.ygeno.2004.12.002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  17 in total

1.  IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization.

Authors:  Lisa A Joss-Moore; Yan Wang; Elizabeth M Ogata; Anthony J Sainz; Xing Yu; Christopher W Callaway; Robert A McKnight; Kurt H Albertine; Robert H Lane
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-03-21

2.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

Review 3.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

4.  Alternative polyadenylation of MeCP2: Influence of cis-acting elements and trans-acting factors.

Authors:  Catherine M Newnham; Tyra Hall-Pogar; Songchun Liang; Jing Wu; Bin Tian; Jim Hu; Carol S Lutz
Journal:  RNA Biol       Date:  2010-05-16       Impact factor: 4.652

5.  MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212.

Authors:  Heh-In Im; Jonathan A Hollander; Purva Bali; Paul J Kenny
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

Review 6.  Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.

Authors:  Robby Mathew Zachariah; Mojgan Rastegar
Journal:  Neural Plast       Date:  2012-02-09       Impact factor: 3.599

Review 7.  Role of mecp2 in experience-dependent epigenetic programming.

Authors:  Christoph A Zimmermann; Anke Hoffmann; Florian Raabe; Dietmar Spengler
Journal:  Genes (Basel)       Date:  2015-03-06       Impact factor: 4.096

8.  Novel recognition motifs and biological functions of the RNA-binding protein HuD revealed by genome-wide identification of its targets.

Authors:  Federico Bolognani; Tania Contente-Cuomo; Nora I Perrone-Bizzozero
Journal:  Nucleic Acids Res       Date:  2009-10-21       Impact factor: 16.971

Review 9.  MECP2 genomic structure and function: insights from ENCODE.

Authors:  Jasmine Singh; Alka Saxena; John Christodoulou; David Ravine
Journal:  Nucleic Acids Res       Date:  2008-09-27       Impact factor: 16.971

Review 10.  The Utility of Next-Generation Sequencing in Gene Discovery for Mutation-Negative Patients with Rett Syndrome.

Authors:  Wendy Anne Gold; John Christodoulou
Journal:  Front Cell Neurosci       Date:  2015-07-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.